Product NDC: | 63629-4790 |
Proprietary Name: | Loratadine D |
Non Proprietary Name: | Loratadine, Pseudoephedrine |
Active Ingredient(s): | 5; 120 mg/1; mg/1 & nbsp; Loratadine, Pseudoephedrine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63629-4790 |
Labeler Name: | Bryant Ranch Prepack |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076050 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120119 |
Package NDC: | 63629-4790-1 |
Package Description: | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4790-1) |
NDC Code | 63629-4790-1 |
Proprietary Name | Loratadine D |
Package Description | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4790-1) |
Product NDC | 63629-4790 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Loratadine, Pseudoephedrine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120119 |
Marketing Category Name | ANDA |
Labeler Name | Bryant Ranch Prepack |
Substance Name | LORATADINE; PSEUDOEPHEDRINE SULFATE |
Strength Number | 5; 120 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |